Skip to main content
OpenTrials

Clinical trial condition

Gallbladder Neoplasms

Explore clinical trials studying Gallbladder Neoplasms. Study availability and eligibility vary by location and protocol.

208 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Gallbladder Neoplasms trial results

Completed

Validation of the Association Between the Abundance of Three Bacterial Genera in Stool Samples and the Risk of Gallbladder Cancer in South American Patients With Gallstones

NCT07635745

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Digestive System Diseases, +6 more
Locations
  • Caja Nacional de Seguro Social Cochabamba, Complejo Hospitalario Viedma, Instituto Gastroenterológico Cochabamba, Bolivia
  • Hospital Dr. Hernán Henriquez Aravena, Complejo Asistencial Padre las Casas, Hospital Regional de Talca, Hospital Regional de Concepción, Hospital Regional de Arica Talca, Chile
  • Statistical Genetics Research Group, Institute of Medical Biometry, University of Heidelberg Heidelberg, Germany
  • Instituto Regional de Enfermedades Neoplasicas del Sur (IREN SUR), Hospital Regional Honorio Delgado Espinoza, Hospital Goyeneche Arequipa, Hospital Regional Manuel Nuñez Butron-Puno Arequipa, Peru
View Trial Details
Completed

Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)-China Extension Study

NCT04924062

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +14 more
Locations
  • Anhui Provincial Hospital ( Site 0140) Hefei, Anhui, China
  • Beijing Cancer Hospital ( Site 0138) Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital ( Site 0150) Beijing, Beijing Municipality, China
  • First Affiliated Hospital of The Third Military Medical University ( Site 0130) Chongqing, Chongqing Municipality, China
View all 22 locations
View Trial Details
Completed

Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)

NCT04003636

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +14 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Ctr ( Site 0016) Birmingham, Alabama, United States
  • University of California San Diego Moores Cancer Center ( Site 0008) La Jolla, California, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 0014) Los Angeles, California, United States
  • University of California - San Francisco ( Site 0030) San Francisco, California, United States
View all 185 locations
View Trial Details
Completed

Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

NCT03768414

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +27 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 692 locations
View Trial Details
Completed

A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers

NCT04466891

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Digestive System Diseases, +6 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California Los Angeles Santa Monica, California, United States
View all 67 locations
View Trial Details
Completed

A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

NCT04853017

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Cancer, +57 more
Locations
  • City of Hope Duarte, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of Colorado Aurora, Colorado, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

NCT05007106

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more
Locations
  • Alaska Womens Cancer Care ( Site 1016) Anchorage, Alaska, United States
  • City of Hope Comprehensive Cancer Center ( Site 1001) Duarte, California, United States
  • University of California, Irvine (UCI) Health - UC Irvine Me-Chao Family Comprehensive Cancer Cente Orange, California, United States
  • Karmanos Cancer Institute ( Site 1007) Detroit, Michigan, United States
View all 73 locations
View Trial Details

Related conditions